Single-nucleotide polymorphism rs498055 on chromosome 10q24 is not associated with Alzheimer disease in two independent family samples.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Mammalian ribosomal and chaperone protein RPS3A counteracts α-synuclein aggregation and toxicity in a yeast model system.The Biochemical journal · 2013
   Article
2. No association of dynamin binding protein (DNMBP) gene SNPs and Alzheimer's disease.Neurobiology of aging · 2008
   Article
3. A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.Cell · 2008
   Article
4. Is alpha-T catenin (VR22) an Alzheimer's disease risk gene?Journal of medical genetics · 2007
   Article
5. Lack of association of two chromosome 10q24 SNPs with Alzheimer's disease.Neuroscience letters · 2006
   Article

Corrections and comments

• Comment on
  A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.2006

Authors and funding

5 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as